Prostate Cancer | Emmanuel S Antonarakis, MD

Exploring the Current and Future Role of PARP Inhibition in the Management of Prostate Cancer — Part 1: Featuring slide presentations and discussion with Dr Antonarakis. Genomic Landscape of Prostate Cancer; Incidence of DNA Damage Repair Deficiencies and the Biology of PARP Inhibition Faculty Presentation — Dr Antonarakis (00:00) Discussion (26:52) CME information and select publications